TNF and inflammatory bowel disease: Although the widespread introduction of 5-ASA, corticosteroids, thiopurine, and TNF-α blockers into clinical practice significantly decreased the risk of major surgeries for IBD patients [9–12], high-quality evidences supporting the chemopreventive efficacy of these agents for CAC are either controversial or absent [13–18].